Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V1TS
|
||||
Former ID |
DNC004588
|
||||
Drug Name |
1-Benzyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H12N4O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)CN2C3=C(C(=O)NC2=O)N4C=CC=CC4=N3
|
||||
InChI |
1S/C16H12N4O2/c21-15-13-14(17-12-8-4-5-9-19(12)13)20(16(22)18-15)10-11-6-2-1-3-7-11/h1-9H,10H2,(H,18,21,22)
|
||||
InChIKey |
JHTRSVKUCQEETB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [1] | |
Reactome | Adenosine P1 receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Nucleotide GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
GPCRs, Other | |||||
References | |||||
REF 1 | J Med Chem. 2002 Aug 1;45(16):3337-44.Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.